The University of Arizona’s Dr. Maria Altbach is working with industry to improve MRI detection of liver tumor spread to expand therapeutic options and improve survival of colorectal cancer patients.

University of Arizona pharmacologist Dr. Todd Vanderah discusses how the conditions created by the COVID-19 pandemic and the response could be exacerbating drug use and overdose.

A University of Arizona Cancer Center grant aims to improve colorectal cancer screening in Arizona’s American Indian communities, where screening rates lag behind those for others across the nation.

A $2.8 million grant will fund research to develop an improved therapeutic treatment for acute ischemic stroke patients that may help them recover faster with fewer long-term complications.

Dr. Emmanuel Katsanis is studying a new chemotherapy treatment for patients with blood-related cancers, such as leukemia, who undergo a particular type of bone marrow transplant procedure.

Sarver Heart team led by Khadijah Breathett looking into gender and racial bias found doctors more judgmental on women’s appearance and social support networks, particularly African American women.

Three experts in constitutional law, environmental law and public health write in a new essay that one of America’s founding documents provides a framework for finding common ground to fight COVID-19.

With 19 new companies added to its roster last fiscal year, the University of Arizona has now launched more than 100 startups since revamping its commercialization operation in late 2012.

The university will offer four class formats and implement a range of safety measures on campus when the fall semester begins on Aug. 24 as scheduled with a mix of in-person and remote instruction.

New findings by University of Arizona College of Medicine – Tucson chemists Drs. Wolfgang Peti and Rebecca Page provide a foundation to better understand and treat these neurological disorders.